Discussion of "A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III" by Andrew G. Chapple and Peter F. Thall. Issue 2 (3rd April 2019)

Record Type:: Journal Article
Title:: Discussion of "A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III" by Andrew G. Chapple and Peter F. Thall. Issue 2 (3rd April 2019)
Main Title:: Discussion of "A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III" by Andrew G. Chapple and Peter F. Thall
Authors:: Leifer, Eric S.
Geller, Nancy L.
Abstract:
Is Part Of:: Biometrics. Volume 75:Issue 2(2019)
Journal:: Biometrics
Issue:: Volume 75:Issue 2(2019)
Issue Display:: Volume 75, Issue 2 (2019)
Year:: 2019
Volume:: 75
Issue:: 2
Issue Sort Value:: 2019-0075-0002-0000
Page Start:: 382
Page End:: 384
Publication Date:: 2019-04-03
Subjects:: Biometry -- Periodicals
570.15195
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/biom.12993 ↗
Languages:: English
ISSNs:: 0006-341X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2088.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 14797.xml